Anti-Müllerian hormone levels during hormonal contraception in women with polycystic ovary syndrome
- 1 October 2007
- journal article
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 134 (2), 196-201
- https://doi.org/10.1016/j.ejogrb.2007.01.012
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Serum anti-müllerian hormone levels in women with secondary amenorrheaFertility and Sterility, 2006
- Combined oral contraceptives in the treatment of polycystic ovary syndromeHuman Reproduction Update, 2005
- Müllerian-inhibiting substance in women with polycystic ovary syndrome: Relationship with hormonal and metabolic characteristicsFertility and Sterility, 2004
- Acog Practice Bulletin. No 41, December 2002. Polycistic Ovary SyndromeInternational Journal of Gynecology & Obstetrics, 2003
- Expression of Anti-Mullerian Hormone during Normal and Pathological Gonadal Development: Association with Differentiation of Sertoli and Granulosa CellsJournal of Clinical Endocrinology & Metabolism, 1999
- Antimullerian Hormone in Patients with Hypogonadotropic HypogonadismJournal of Clinical Endocrinology & Metabolism, 1999
- Prevalence of the Polycystic Ovary Syndrome in Unselected Black and White Women of the Southeastern United States: A Prospective StudyJournal of Clinical Endocrinology & Metabolism, 1998
- Anti-mullerian hormone and anti-mullerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle, and gonadotropin-induced follicle growthEndocrinology, 1995
- Anti-Müllerian hormone in early human developmentEarly Human Development, 1993
- Medical implications of ultrasonically detected polycystic ovariesJournal of Clinical Ultrasound, 1981